InfuSystem Holdings, Inc.

INFU

US45685K1025

Medical Equipment, Supplies & Distribution

Market Closed - Nyse Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
8.12 ^USD	+6.70%		-0.98%	-22.96%

Apr. 10	Gregg Lehman Not to Stand for Re-Election as Director of InfuSystem Holdings, Inc	CI
Mar. 14	Transcript : InfuSystem Holdings, Inc., Q4 2023 Earnings Call, Mar 14, 2024

InfuSystem Holdings, Inc. Provides Earnings Guidance for the Full Year 2024

March 14, 2024 at 06:31 am EDT

InfuSystem Holdings, Inc. provided earnings guidance for the full year 2024. For the period, the company's net revenue growth estimated to be in the high-single-digit range.

Latest news about InfuSystem Holdings, Inc.

Gregg Lehman Not to Stand for Re-Election as Director of InfuSystem Holdings, Inc	Apr. 10	CI
Transcript : InfuSystem Holdings, Inc., Q4 2023 Earnings Call, Mar 14, 2024	Mar. 14
Infusystem Announces Operational And Financial Results For Q4 And FY 2023	Mar. 14	RE
Earnings Flash (INFU) INFUSYSTEM HOLDINGS Reports Q4 Revenue $31.8M	Mar. 14	MT
InfuSystem Holdings, Inc. Provides Earnings Guidance for the Full Year 2024	Mar. 14	CI
InfuSystem Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 14	CI
InfuSystem Holdings, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 14	CI
InfuSystem Holdings, Inc. Announces Resignation of R. Rimmy Malhotra as Member of the Board	Mar. 08	CI
Tranche Update on InfuSystem Holdings, Inc.'s Equity Buyback Plan announced on June 30, 2021.	Nov. 09	CI
Transcript : InfuSystem Holdings, Inc., Q3 2023 Earnings Call, Nov 07, 2023	Nov. 07
Earnings Flash (INFU) INFUSYSTEM HOLDINGS Reports Q3 Revenue $31.9M	Nov. 07	MT
InfuSystem Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 07	CI
InfuSystem Holdings, Inc. Provides Revenue Guidance for the Fourth Quarter of 2023	Nov. 07	CI
InfuSystem Holdings, Inc. Raises Earnings Guidance for the Full Year 2023	Nov. 07	CI
InfuSystem, Dignitana Sign Sales, Marketing Partnership to Offer DigniCap Scalp Cooling System in the US	23-10-04	MT
Dignitana Signs Sales & Marketing Deal With US-based InfuSystem; Shares Drop	23-10-04	MT
Dignitana AB Announces Sales and Marketing Partnership with InfuSystem Holdings, Inc. to Provide Scalp Cooling Systems in the United States	23-10-04	CI
Tranche Update on InfuSystem Holdings, Inc.'s Equity Buyback Plan announced on June 30, 2021.	23-08-09	CI
Transcript : InfuSystem Holdings, Inc., Q2 2023 Earnings Call, Aug 03, 2023	23-08-03
Earnings Flash (INFU) INFUSYSTEM HOLDINGS Posts Q2 Revenue $31.7M	23-08-03	MT
InfuSystem Holdings, Inc. Revises Earnings Guidance for the Year 2023	23-08-03	CI
InfuSystem Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-03	CI
InfuSystem Holdings, Inc.(NYSEAM:INFU) added to Russell 3000E Growth Index	23-06-23	CI
InfuSystem Holdings, Inc.(NYSEAM:INFU) added to Russell Small Cap Completeness Index	23-06-23	CI
InfuSystem Holdings, Inc.(NYSEAM:INFU) added to Russell Small Cap Comp Growth Index	23-06-23	CI

Chart InfuSystem Holdings, Inc.

Duration

Period

More charts

InfuSystem Holdings, Inc. is a health care service provider that facilitates outpatient care for durable medical equipment manufacturers and health care providers. The Companyâs segments include Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). The Companyâs core service within its ITS segment is its Oncology Business. The ITS segment supplies electronic ambulatory infusion pumps and associated disposable supply kits to private oncology clinics, infusion clinics and hospital outpatient oncology clinics to be utilized in the treatment of a variety of cancers, including colorectal cancer and other disease states. Its DME Services segments core service is to sell or rent new and pre-owned pole-mounted and ambulatory infusion pumps and other Durable Medical Equipment; sell treatment-related consumables; and provide biomedical recertification, maintenance and repair services for oncology practices as well as other healthcare site settings.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-05-01 - Q1 2024 Earnings Release (Projected)

Related indices

Russell 2000

More about the company

Income Statement Evolution

More financial data

Ratings for InfuSystem Holdings, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

C-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

8.12 USD

Average target price

14.75 USD

Spread / Average Target

+81.65%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
INFUSYSTEM HOLDINGS, INC.	-22.96%	173M
ABBOTT LABORATORIES	-2.31%	187B
MEDTRONIC PLC	-3.20%	106B
BECTON, DICKINSON AND COMPANY	-5.04%	66.9B
DEXCOM, INC.	+0.20%	49.45B
CENCORA, INC.	+17.29%	48B
HOYA CORPORATION	+4.06%	40.84B
METTLER-TOLEDO INTERNATIONAL, INC.	+2.07%	26.48B
WEST PHARMACEUTICAL SERVICES, INC.	+2.36%	26.25B
TERUMO CORPORATION	+12.96%	24.62B

Other Medical Equipment, Supplies & Distribution